Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/Safety of Aztreonam-Avibactam in Healthy Chinese Participants
NCT04973826Phase 1Completed
- Sponsor
- Pfizer
- Start
- Aug 2021
- Primary completion
- Sep 2021
- Modality
- Covalent Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of aztreonam + avibactam in bacterial infection, sponsored by Pfizer. Primary endpoints: Maximum Observed Plasma Concentration at Day 4, Area Under the Plasma Concentration-Time Profile From Time 0 to 6 Hours and 5 more. Started Aug 2021; status: completed.
02
Drugs
aztreonam + avibactam
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT04973826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04973826.